Search Count: 47
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2019-07-03 Classification: chaperone/chaperone inhibitor Ligands: KFY |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2019-07-03 Classification: chaperone/chaperone inhibitor Ligands: KFY |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2019-07-03 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: KFY |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.02 Å Release Date: 2017-03-08 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 6TN |
 |
Crystal Structure Of The Human Hsp90-Alpha N-Domain Bound To The Hsp90 Inhibitor Fj6
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-07-13 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: FJS |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40W |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40Y, GOL |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40X, GOL |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40Z, GOL |
 |
Heat Shock Protein 70 Substrate Binding Domain With Covalently Linked Novolactone
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.42 Å Release Date: 2015-01-14 Classification: chaperone/chaperone inhibitor Ligands: 3UM |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-24 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q8 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2014-11-05 Classification: Chaperone/Chaperone Inhibitor Ligands: JR9 |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:3.45 Å Release Date: 2014-09-10 Classification: Chaperone/Chaperone inhibitor Ligands: 3JE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2014-06-18 Classification: Chaperone/Chaperone Inhibitor Ligands: RL1 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2014-06-18 Classification: Chaperone/Chaperone Inhibitor Ligands: RL3 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2014-06-18 Classification: Chaperone/Chaperone Inhibitor Ligands: X29 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2014-06-18 Classification: Chaperone/Chaperone Inhibitor Ligands: S36 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2014-06-18 Classification: Chaperone/Chaperone Inhibitor Ligands: S46 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q9 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: FGH |